FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077581063> ?p ?o ?g. }

• W2077581063 endingPage "348" @default.
• W2077581063 startingPage "345" @default.
• W2077581063 abstract "Objectives To study the feasibility of 5-aminolevulinic-acid (5-ALA)-induced photodynamic diagnosis (PDD) for the evaluation of the surgical margins (SMs) during radical prostatectomy (RP) in patients with prostate cancer (PCa). Methods A total of 18 patients with histologically confirmed PCa (Gleason score 4 to 8, prostate-specific antigen 1 to 20 ng/mL) underwent RP. Of the 18 patients, 16 received 5-ALA (20 mg/kg) orally 2 hours before RP, and 2 served as controls without any application of 5-ALA. To study the protoporphyrin IX (PPIX) accumulation after application of 5-ALA, all harvested specimens were investigated by fluorescence microscopy and spectroscopy. In 10 of 16 patients, PDD of the SMs and the prostate was performed during RP using an incoherent light source filtered for efficient fluorescence excitation. Results In all 16 patients, who had received 5-ALA fluorescence microscopy showed a selective accumulation of PPIX in the PCa cells, and only weak PPIX fluorescence could be detected in benign epithelial cells and none in the adjacent stroma. The 2 patients, who had not received 5-ALA had no PPIX fluorescence in the prostate. Of 10 patients, 8 demonstrated fluorescence-negative and histologically confirmed negative margins during PDD, and 1 each demonstrated a fluorescence-positive SM that was also confirmed by histologic examination and a positive SM that was not confirmed by PPD. Conclusions This is the first report of PDD for PCa using 5-ALA. These initial results have demonstrated that PPIX is selectively enhanced in malignant tissue, an essential prerequisite of PDD. Additional studies are warranted to validate these preliminary data and the efficacy of PDD for PCa during RP. To study the feasibility of 5-aminolevulinic-acid (5-ALA)-induced photodynamic diagnosis (PDD) for the evaluation of the surgical margins (SMs) during radical prostatectomy (RP) in patients with prostate cancer (PCa). A total of 18 patients with histologically confirmed PCa (Gleason score 4 to 8, prostate-specific antigen 1 to 20 ng/mL) underwent RP. Of the 18 patients, 16 received 5-ALA (20 mg/kg) orally 2 hours before RP, and 2 served as controls without any application of 5-ALA. To study the protoporphyrin IX (PPIX) accumulation after application of 5-ALA, all harvested specimens were investigated by fluorescence microscopy and spectroscopy. In 10 of 16 patients, PDD of the SMs and the prostate was performed during RP using an incoherent light source filtered for efficient fluorescence excitation. In all 16 patients, who had received 5-ALA fluorescence microscopy showed a selective accumulation of PPIX in the PCa cells, and only weak PPIX fluorescence could be detected in benign epithelial cells and none in the adjacent stroma. The 2 patients, who had not received 5-ALA had no PPIX fluorescence in the prostate. Of 10 patients, 8 demonstrated fluorescence-negative and histologically confirmed negative margins during PDD, and 1 each demonstrated a fluorescence-positive SM that was also confirmed by histologic examination and a positive SM that was not confirmed by PPD. This is the first report of PDD for PCa using 5-ALA. These initial results have demonstrated that PPIX is selectively enhanced in malignant tissue, an essential prerequisite of PDD. Additional studies are warranted to validate these preliminary data and the efficacy of PDD for PCa during RP." @default.
• W2077581063 created "2016-06-24" @default.
• W2077581063 creator A5001964315 @default.
• W2077581063 creator A5015166432 @default.
• W2077581063 creator A5030545703 @default.
• W2077581063 creator A5031181995 @default.
• W2077581063 creator A5032723248 @default.
• W2077581063 creator A5048585208 @default.
• W2077581063 creator A5066330818 @default.
• W2077581063 creator A5068751801 @default.
• W2077581063 creator A5075552696 @default.
• W2077581063 creator A5077407579 @default.
• W2077581063 creator A5081515243 @default.
• W2077581063 creator A5081961546 @default.
• W2077581063 creator A5084527744 @default.
• W2077581063 date "2008-08-01" @default.
• W2077581063 modified "2023-10-16" @default.
• W2077581063 title "Photodynamic Diagnosis of Prostate Cancer Using 5-Aminolevulinic Acid—First Clinical Experiences" @default.
• W2077581063 cites W1513986580 @default.
• W2077581063 cites W1972849233 @default.
• W2077581063 cites W1997563283 @default.
• W2077581063 cites W2008385385 @default.
• W2077581063 cites W2009824150 @default.
• W2077581063 cites W2018351351 @default.
• W2077581063 cites W2024285006 @default.
• W2077581063 cites W2038703165 @default.
• W2077581063 cites W2056839504 @default.
• W2077581063 cites W2092995389 @default.
• W2077581063 cites W2122620614 @default.
• W2077581063 cites W2131034864 @default.
• W2077581063 cites W2133858000 @default.
• W2077581063 cites W2149083988 @default.
• W2077581063 cites W2156528952 @default.
• W2077581063 cites W31616992 @default.
• W2077581063 doi "https://doi.org/10.1016/j.urology.2007.12.086" @default.
• W2077581063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18405945" @default.
• W2077581063 hasPublicationYear "2008" @default.
• W2077581063 type Work @default.
• W2077581063 sameAs 2077581063 @default.
• W2077581063 citedByCount "52" @default.
• W2077581063 countsByYear W20775810632012 @default.
• W2077581063 countsByYear W20775810632013 @default.
• W2077581063 countsByYear W20775810632014 @default.
• W2077581063 countsByYear W20775810632015 @default.
• W2077581063 countsByYear W20775810632016 @default.
• W2077581063 countsByYear W20775810632017 @default.
• W2077581063 countsByYear W20775810632020 @default.
• W2077581063 countsByYear W20775810632021 @default.
• W2077581063 countsByYear W20775810632022 @default.
• W2077581063 countsByYear W20775810632023 @default.
• W2077581063 crossrefType "journal-article" @default.
• W2077581063 hasAuthorship W2077581063A5001964315 @default.
• W2077581063 hasAuthorship W2077581063A5015166432 @default.
• W2077581063 hasAuthorship W2077581063A5030545703 @default.
• W2077581063 hasAuthorship W2077581063A5031181995 @default.
• W2077581063 hasAuthorship W2077581063A5032723248 @default.
• W2077581063 hasAuthorship W2077581063A5048585208 @default.
• W2077581063 hasAuthorship W2077581063A5066330818 @default.
• W2077581063 hasAuthorship W2077581063A5068751801 @default.
• W2077581063 hasAuthorship W2077581063A5075552696 @default.
• W2077581063 hasAuthorship W2077581063A5077407579 @default.
• W2077581063 hasAuthorship W2077581063A5081515243 @default.
• W2077581063 hasAuthorship W2077581063A5081961546 @default.
• W2077581063 hasAuthorship W2077581063A5084527744 @default.
• W2077581063 hasConcept C121332964 @default.
• W2077581063 hasConcept C121608353 @default.
• W2077581063 hasConcept C126322002 @default.
• W2077581063 hasConcept C126894567 @default.
• W2077581063 hasConcept C142724271 @default.
• W2077581063 hasConcept C169274487 @default.
• W2077581063 hasConcept C178790620 @default.
• W2077581063 hasConcept C185592680 @default.
• W2077581063 hasConcept C204232928 @default.
• W2077581063 hasConcept C2776235491 @default.
• W2077581063 hasConcept C2779466945 @default.
• W2077581063 hasConcept C2779671804 @default.
• W2077581063 hasConcept C2780192828 @default.
• W2077581063 hasConcept C2781323092 @default.
• W2077581063 hasConcept C52124034 @default.
• W2077581063 hasConcept C62520636 @default.
• W2077581063 hasConcept C71924100 @default.
• W2077581063 hasConcept C91881484 @default.
• W2077581063 hasConceptScore W2077581063C121332964 @default.
• W2077581063 hasConceptScore W2077581063C121608353 @default.
• W2077581063 hasConceptScore W2077581063C126322002 @default.
• W2077581063 hasConceptScore W2077581063C126894567 @default.
• W2077581063 hasConceptScore W2077581063C142724271 @default.
• W2077581063 hasConceptScore W2077581063C169274487 @default.
• W2077581063 hasConceptScore W2077581063C178790620 @default.
• W2077581063 hasConceptScore W2077581063C185592680 @default.
• W2077581063 hasConceptScore W2077581063C204232928 @default.
• W2077581063 hasConceptScore W2077581063C2776235491 @default.
• W2077581063 hasConceptScore W2077581063C2779466945 @default.
• W2077581063 hasConceptScore W2077581063C2779671804 @default.
• W2077581063 hasConceptScore W2077581063C2780192828 @default.
• W2077581063 hasConceptScore W2077581063C2781323092 @default.
• W2077581063 hasConceptScore W2077581063C52124034 @default.
• W2077581063 hasConceptScore W2077581063C62520636 @default.

• next